Simplified quantification of insulin, its synthetic analogs and C‐peptide in human plasma by means of LC‐HRMS
Open Access
- 12 January 2020
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 12 (3) , 382-390
Abstract
The quantification of peptide hormones by means of liquid chromatography (LC) coupled to mass spectrometry (MS) or other techniques (e.g. immunoassays) has been a challenging task in modern analytical chemistry. Especially for insulin, its synthetic analogs, and C‐peptide, reliable determinations are urgently needed due to their diagnostic value in the management of diabetes and insulin resistance and because of the illicit use of insulin as a performance‐enhancing agent in professional sports or as an effective toxin in forensic toxicology. The concomitant measurement of C‐peptide and insulin offers an established tool for the diagnostic workup of hypoglycemia (endogenous vs. exogenous hyperinsulinemia), characterizing hepatic insulin clearance, and the assessment of beta‐cell function (insulin secretion). Thus, the present approach offers the possibility to determine human insulin and its synthetic analogs (lispro, glulisine, aspart, glargine metabolite, degludec, detemir, porcine, and bovine) and C‐peptide simultaneously after sample preparation utilizing protein precipitation and a mixed‐mode cation‐exchange solid‐phase extraction, and subsequent detection by LC‐high resolution MS. The method was fully validated regarding the following parameters: specificity, limit of detection (0.2 ng/mL), limit of quantification (0.6 ng/mL), recovery (40–90%), accuracy (78–128%), linearity, precision (< 21%), carry over, robustness, and matrix effects. The proof‐of‐concept was shown by analyzing authentic plasma samples from adults with class II obesity and prediabetes collected in the course of an oral glucose tolerance test. All sample preparation steps were controlled by two stable isotope‐labeled internal standards, namely [[2H10] Leu B6, B11, B15, B17]‐insulin, and [[13C6] Leu 26, 30] C‐peptide.Keywords
This publication has 20 references indexed in Scilit:
- Direct comparison of LC–MS/MS and RIA methods for the pharmacokinetics assessment of human insulin in preclinical developmentBiomedical Chromatography, 2018
- Simultaneous determination of insulin, DesB30 insulin, proinsulin, and C-peptide in human plasma samples by liquid chromatography coupled to high resolution mass spectrometryForensic Toxicology, 2016
- An automated, high‐throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA‐HR/AM)Proteomics, 2014
- Multidimensional LC-MS/MS Enables Simultaneous Quantification of Intact Human Insulin and Five Recombinant Analogs in Human PlasmaAnalytical Chemistry, 2013
- Advances in The Quantitation of Therapeutic Insulin Analogues by LC–MS/MSBioanalysis, 2013
- Quantitative Insulin Analysis Using Liquid Chromatography–Tandem Mass Spectrometry in a High-Throughput Clinical LaboratoryClinical Chemistry, 2013
- New liquid chromatography/electrospray ionisation tandem mass spectrometry measurement procedure for quantitative analysis of human insulin in serumRapid Communications in Mass Spectrometry, 2007
- Biotransformation of insulin glargine after subcutaneous injection in healthy subjectsCurrent Medical Research and Opinion, 2003
- A Stable Isotope Dilution Assay for the In Vivo Determination of Insulin Levels in Humans by Mass SpectrometryDiabetes, 1997
- The kinetics of insulin in man. II. Role of the liverDiabetes/Metabolism Research and Reviews, 1987